Predict your next investment

Luna PBC company logo
Corporation
INTERNET | Internet Software & Services / Healthcare
lunadna.com

See what CB Insights has to offer

Founded Year

2017

Stage

Unattributed | Alive

Total Raised

$12.4M

Last Raised

$3.8M | 6 mos ago

About Luna PBC

Luna PB is the creator of LunaDNA, a health and genomic data platform owned by its community of personal health information donors. LunaDNA empowers individuals to share their health data for medical research and the greater good of the community. As community owners in the LunaDNA platform, members share in the value created from health discoveries and medical breakthroughs.

Luna PBC Headquarter Location

4110 Campus Point Court

San Diego, California, 92121,

United States

Latest Luna PBC News

LunaPBC is trading company shares for member health data

Jul 23, 2019

MedCity News LunaPBC is trading company shares for member health data On the company's LunaDNA platform, a whole genome can be exchanged for 300 company shares, while 20 days of fitness data is equal to two shares. Shares0 The growing chorus of concern over the way consumer health data is being sold and used has led to the emergence of new models meant to give individuals ownership of their own data. One San Diego startup is trying to create a system where health data can be exchanged for an ownership stake in the company itself. LunaPBC was founded by former executives at genetic sequencing company Illumina with the intention create a community-owned platform for the secure sharing of health information in a way to reward the actual contributors of the data. CEO Bob Kain said the company was born in response to the broad way that consumers were unknowingly giving companies control over their personal health data, coupled with the potential benefit from breaking down data silos to reveal new insights and discoveries. When users contribute their data to the LunaPBC-managed LunaDNA platform , personal identifiers are stripped away and researchers or commercials partners are only allowed to access the data in an aggregated manner. Kain used the example of a researcher from the pharmaceutical industry looking for individuals of a certain age and sex who have been diagnosed with a specific disease. The researcher could then run a query among that population to find whether there was something common within their genome. “That’s how we can move research forward by finding correlation but not compromising anybody’s privacy or ability to control their data,” said Kain. He added that members have the option to delete their data from the platform at any time. In May, the 20-person company raised a $4.6 million funding round from investors including ARCH Venture Partners, Bain Capital Ventures and Illumina Ventures to boost the growth of its platform and expand into new data type like EHR information, fitness tracking and microbiome data. The company has raised a total of $7.6 million since its founding in 2017. Initially, the platform was launched as a blockchain system to trade data in exchange for cryptocurrency, mirroring the approach taken by companies like Nebula Genomics and  EncrypGen . However, Kain said the SEC’s shifting regulation around cryptocurrency token offerings led the company toward a new direction. In December, LunaPBC received a novel qualification by the SEC to allow the exchange of company ownership shares for member provided data in a Tier 2 Regulation A offering. The exchange rate is commensurate to the utility and scale of the data shared, ranging from a whole genome (which trades for 300 company shares) to 20 days of fitness monitoring data (2 shares) to DNA targeted genes (10 shares). Currently the estimated fair market value for a whole genome is only $21, but the idea is that more members contributing data will boost the value of the platform and company through a network effect. A full list of the data able to be exchanged on the platform can be seen in this SEC filing . The company doesn’t perform actual genetic sequencing, instead focusing on data management, but accepts data files from companies like 23andMe, AncestryDNA, MyHeritage and FamilyTree DNA. However, LunaPBC differentiates its model to the aforementioned companies by providing payment for the use of member data. The shares are non transferable and can’t be bought or sold like traditional stocks. Instead the way that members financially benefit from the use of their data is through dividends that are paid out when their data is used. Net proceeds from commercial partnerships are divided on a 50-50 basis between LunaPBC and community members who receive a reward based on their ownership stake. “We see ourselves as basically a data hub where we can bring people together and they can move up the value chain together and enjoy in the nonlinear increase in value that is achieved by aggregating all this data,” Kain said. “I really believe in the end what’s going to make this sticky as it is when people start to see us creating discoveries that are helping their friends and family members and maybe leaving a legacy for future generations.” Pharmaceutical companies represent a major potential partner for LunaPBC, who can help accelerate the drug development process by helping streamline clinical trial recruitment, clinical trial engagement and the collection of real-world evidence. “Giving a pharma company back six months to a year of life on a blockbuster drug could mean a billion dollars more revenue before a generic comes out,” Kain said. “What they tell us is that ‘we know we need larger pools of data and we’re looking to partner with other pharma companies in order to increase our data size, but we also need a relationship with the individual and we don’t know how to do that.’” The company also seeks to work with nonprofits and academic institutions on accelerating research. Some of the company’s initial collaborations have been with rare disease patient groups. Earlier this year, LunaPBC signed a deal with the Genetic Alliance to incorporate the nonprofit’s health data portal system onto the LunaDNA platform. Genetic Alliance’s PEER registry has more than 50,000 individuals across more than 50 different conditions or diseases. Picture: Altayb, Getty Images

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Luna PBC

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Luna PBC in 3 CB Insights research briefs, most recently on Oct 2, 2019.

Expert Collections containing Luna PBC

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Luna PBC is included in 4 Expert Collections, including Digital Health 150.

D

Digital Health 150

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

G

Game Changers 2018

36 items

Our selected startups are high-momentum companies pioneering technology with the potential to transform society and economies for the better.

O

Omics

1,029 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

D

Digital Health

11,293 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Luna PBC Patents

Luna PBC has filed 10 patents.

The 3 most popular patent topics include:

  • Biological databases
  • Bioinformatics
  • Data management
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/30/2019

7/27/2021

Cryptocurrencies, Data management, Health informatics, Social networking services, Alternative currencies

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/30/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

7/27/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Cryptocurrencies, Data management, Health informatics, Social networking services, Alternative currencies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Luna PBC Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Luna PBC Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.